Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Rituximab in combination with gemcitabine plus cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma: a phase I trial

Fig. 4

Peripheral blood immune cell profile. CD20 count on days 0 and 7. a Peripheral immune cell profile in non-classical monocyte responders and non-responders including b CD19+CD20+, c CD4, d CD8, e CD4/CD8 ratio, f regulatory T cell/CD8 ratio, g classical monocytes, h intermediate monocytes, and i non-classical monocytes. The results were analyzed using the Mann–Whitney U test (n = 3 + 7)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us